An expert panel of the central drug authority of India (DCGI) has recommended the permission for conducting phase-3 clinical trial of single-dose Covid-19 vaccine ‘Sputnik Light’ as a booster dose, official sources said on Saturday. Now the ball lies in the court of the DCGI to whether or not to approve it
The recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval.
The DCGI had on February 4 granted emergency use permission to Sputnik Light vaccine in India, subject to certain regulatory provisions.
Hyderabad-based Dr. Reddy’s Laboratories had presented its proposal to DCGI for conducting the phase-3 trial of Sputnik Light vaccine as a booster dose.
